☰

Leslimar Rios-Colon - Publications

Affiliations: 
CHDMM Loma Linda University, Loma Linda, United States 
Tree Info Similar researchers PubMed Report error

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Rios-Colon L, Kumar P, Kim S, Sharma M, Su Y, Kumar A, Singh S, Stocks N, Liu L, Joshi M, Schlaepfer IR, Kumar D, Deep G. Carnitine Palmitoyltransferase 1 Regulates Prostate Cancer Growth under Hypoxia. Cancers. 13. PMID 34944922 DOI: 10.3390/cancers13246302  0.34
2019 Rios-Colon L, Deep G, Kumar D. Emerging role of microRNA 628-5p as a novel biomarker for cancer and other diseases. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 41: 1010428319881344. PMID 31608792 DOI: 10.1177/1010428319881344  0.357
2019 Cagle P, Niture S, Srivastava A, Ramalinga M, Aqeel R, Rios-Colon L, Chimeh U, Suy S, Collins SP, Dahiya R, Kumar D. MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cells. Scientific Reports. 9: 9776. PMID 31278310 DOI: 10.1038/s41598-019-46170-3  0.379
2019 Cagle P, Niture S, Srivastava A, Ramalinga M, Rios-Colon L, Chimeh U, Kumar D. Abstract 3561: MicroRNA-214 inhibits prostate cancer cell proliferation, migration, invasion and increases drug sensitivity by targeting PTK6 Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-3561  0.486
2019 Panigrahi G, Su Y, Rios-Colon L, Peak T, Sai K, Praharaj P, Lee J, Furdui C, Hemal A, Kumar D, Deep G. Abstract 2653: Usefulness of plasma exosomes to characterize hypoxic phenotype in primary prostate tumors Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2653  0.357
2018 Cajigas-Du Ross CK, Martinez SR, Woods-Burnham L, Durán AM, Roy S, Basu A, Ramirez JA, Ortiz-Hernández GL, Ríos-Colón L, Chirshev E, Sanchez-Hernandez ES, Soto U, Greco C, Boucheix C, Chen X, et al. RNA sequencing reveals upregulation of a transcriptomic program associated with stemness in metastatic prostate cancer cells selected for taxane resistance. Oncotarget. 9: 30363-30384. PMID 30100995 DOI: 10.18632/Oncotarget.25744  0.72
2017 Ríos-Colón L, Cajigas-Du Ross CK, Basu A, Elix C, Alicea-Polanco I, Sanchez TW, Radhakrishnan V, Chen CS, Casiano CA. Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes. Oncotarget. PMID 28212536 DOI: 10.18632/Oncotarget.15323  0.848
2017 Ross CKC, Rios-Colon L, Woods-Burnham L, Casiano CA. Abstract 4167: Co-targeting the stress survival proteins LEDGF/p75 and clusterin to resensitize chemoresistant prostate cancer cells to docetaxel Cancer Research. 77: 4167-4167. DOI: 10.1158/1538-7445.Am2017-4167  0.871
2016 Basu A, Cajigas-Du Ross CK, Rios-Colon L, Mediavilla-Varela M, Daniels-Wells TR, Leoh LS, Rojas H, Banerjee H, Martinez SR, Acevedo-Martinez S, Casiano CA. LEDGF/p75 Overexpression Attenuates Oxidative Stress-Induced Necrosis and Upregulates the Oxidoreductase ERP57/PDIA3/GRP58 in Prostate Cancer. Plos One. 11: e0146549. PMID 26771192 DOI: 10.1371/Journal.Pone.0146549  0.815
2016 Rios-Colon L, Sanchez TW, Elix CC, Alicea I, Basu A, Ross CD, Neamati N, Casiano CA. Abstract B06: Repositioning HIV-based small molecule inhibitors of the stress oncoprotein LEDGF/p75 to overcome prostate cancer resistance to taxane chemotherapy Cancer Epidemiology, Biomarkers & Prevention. 25. DOI: 10.1158/1538-7755.Disp15-B06  0.83
2015 Basu A, Woods-Burnham L, Ortiz G, Rios-Colon L, Figueroa J, Albesa R, Andrade LE, Mahler M, Casiano CA. Specificity of antinuclear autoantibodies recognizing the dense fine speckled nuclear pattern: Preferential targeting of DFS70/LEDGFp75 over its interacting partner MeCP2. Clinical Immunology (Orlando, Fla.). 161: 241-250. PMID 26235378 DOI: 10.1016/J.Clim.2015.07.014  0.77
2015 Ochs RL, Mahler M, Basu A, Rios-Colon L, Sanchez TW, Andrade LE, Fritzler MJ, Casiano CA. The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding. Clinical and Experimental Medicine. PMID 26088181 DOI: 10.1007/S10238-015-0367-0  0.791
2014 Pacheco FJ, Almaguel FG, Evans W, Rios-Colon L, Filippov V, Leoh LS, Rook-Arena E, Mediavilla-Varela M, De Leon M, Casiano CA. Docosahexanoic acid antagonizes TNF-α-induced necroptosis by attenuating oxidative stress, ceramide production, lysosomal dysfunction, and autophagic features. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. 63: 859-71. PMID 25095742 DOI: 10.1007/S00011-014-0760-2  0.732
2013 Rios-Colon L, Basu A, Elix C, Casiano CA, León MD. Abstract 892: The stress oncoprotein LEDGF/P75 promotes selective resistance to multiple chemotherapeutic drugs in prostate cencer cells. Cancer Research. 73: 892-892. DOI: 10.1158/1538-7445.Am2013-892  0.833
2012 Leoh LS, van Heertum B, De Rijck J, Filippova M, Rios-Colon L, Basu A, Martinez SR, Tungteakkhun SS, Filippov V, Christ F, De Leon M, Debyser Z, Casiano CA. The stress oncoprotein LEDGF/p75 interacts with the methyl CpG binding protein MeCP2 and influences its transcriptional activity. Molecular Cancer Research : McR. 10: 378-91. PMID 22275515 DOI: 10.1158/1541-7786.Mcr-11-0314  0.814
2012 Basu A, Ríos-Colón L, Nishikawa C, Elix C, Nguyen L, Djeu J, León MD, Casiano C. Abstract 775: Targeting the transcriptional coactivator LEDGF/p75 to overcome chemoresistance in prostate cancer Cancer Research. 72: 775-775. DOI: 10.1158/1538-7445.Am2012-775  0.85
2012 Ríos-Colón L, Basu A, Cajigas C, Elix C, Casiano CA. Abstract B76: Circumventing chemoresistance as a strategy to reduce the mortality disparities associated with advanced prostate cancer. Cancer Epidemiology, Biomarkers & Prevention. 21. DOI: 10.1158/1055-9965.Disp12-B76  0.851
2011 Leoh LS, Mediavilla-Varela M, Basu A, Daniels TR, Martinez S, Pacheco FJ, Padilla A, Asuelime G, Rios-Colon L, Leon MD, Casiano CA. Abstract 2083: The stress oncoprotein LEDGF/p75 attenuates oxidative stress-induced necrosis but not apoptosis in prostate cancer cells Cancer Research. 71: 2083-2083. DOI: 10.1158/1538-7445.Am2011-2083  0.78
2010 Leoh LS, Rios-Colon L, Martinez S, Tungteakkhun S, Filippova M, Manuel L, Gijsbers R, Debyser Z, Casiano CA. Abstract 2945: Methyl CpG binding protein MeCP2 interacts with the stress-response transcription coactivator LEDGF/p75 and modulates its survival and transcription functions Cancer Research. 70: 2945-2945. DOI: 10.1158/1538-7445.Am10-2945  0.836
Show low-probability matches.